Alterations of soluble transferrin receptor level in children with chronic hepatitis C during treatment with recombinant interferon-alpha and ribavirin

Hepatology Research

Volumn 33, Issue 1, 2005, Pages 19-23

  Mozer Lisewska, Iwona ^a   Mania, Anna ^a   Kowala Piaskowska, Arleta ^a   Figlerowicz, Magdalena ^a   Słuzewski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Children; Chronic hepatitis C; Interferon; Ribavirin; Transferrin receptor

Indexed keywords

FERRITIN; IRON; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; LATEX AGGLUTINATION TEST; MALE; OBSERVATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 26844461905     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.08.001     Document Type: Article

References (22)

1. A.M. Larson S.L. Taylor D. Bauermeister L. Rosoff Jr. K.V. Kowdley Pilot study of the relationship between histologic progression and hepatic iron concentration in chronic hepatitis C J Clin Gastroenterol 37 2003 406-411
2. A. Piperino M. Sampierto R. Alba et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C Liver 16 1996 248-254
3. G.N. Ioannou B.Y. Tung K.V. Kowdley Iron in hepatitis C: Villain or innocent bystander? Semin Gastrointest Dis 13 2002 95-108
4. E. Boucher A. Bourienne P. Adams B. Turlin P. Brissot Y. Deugnier Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment Gut 41 1997 115-120
5. W. Sievert S. Pianko S. Warner et al. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: A long term follow-up study in hepatitis C-infected patients with beta thalassemia major Am J Gastroenterol 97 2002 982-987
6. M.J. Burt W.G. Cooksley The influence of iron on chronic hepatitis C J Gastroenterol Hepatol 13 1998 330-333
7. S. Distatne K. Bjoro K.B. Hellum et al. Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection Liver 22 2002 269-275
8. H. Van Vlierberghe H. Verdievel I. Colle et al. Non-transferin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients Aliment Pharmacol Ther 16 2002 1555-1562
9. G. Wiess F. Umflauft M. Urbanek et al. Associations between cellular immune effector function, iron metabolism and disease activity in patients with chronic hepatitis C virus infection J Inf Dis 180 1999 1452-1458
10. A.M. DiBisceglie C.A. Axiotinis J.H. Hoofnagle B.R. Bacon Measurements of iron status in patients with chronic hepatitis Gastroententerology 102 1992 2108-2113
11. Y. Kohgo Y. Torimoto J. Kato Transferrin receptor in tissue and serum: updated clinical significance of soluble receptor Int J Hematol 76 2002 213-218
12. E.P. Kuiper-Kramer C.M. Huisman J. van Raan H.G. van Eijk Analytical and clinical implications of soluble transferrin receptors in serum Eur J Clin Chem Clin Biochem 34 1996 645-649
13. R.G. Knodell K.G. Ishak Black et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431-435
14. A. Nagral A.B. Mehta Gomes ATB et al. Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease Clin Lab Haem 21 1999 93-97
15. A.M. DiBisceglie B.R. Bacon D.E. Kleiner J.H. Hoofnagle Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C J Hepatol 21 1994 1109-1112
16. J.K. Olynyk K.R. Reddy A.M. Di Bisceglie et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C Gastroenterology 108 1995 1104-1109
17. N.C. Tsai E. Zuckerman S.H. Han et al. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy Am J Gastroenterol 92 1997 1831-1834
18. T.L. Fong S.H. Han N.C. Tsai et al. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C J Hepatol 28 1998 369-374
19. J.L. Herrera Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy Am J Gastroenterol 94 1999 3571-3575
20. D. Guyader E. Boucher P. Andre et al. A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon Am J Gastroenterol 94 1999 1696-1698
21. A.M. DiBisceglie H.L. Bonkovsky S. Chopra et al. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial Hepatology 32 2000 135-140
22. R.J. Fontana J. Israel P. LeClair et al. Iron reduction before and during interferon therapy of chronic hepatitis C. Results of a multicenter, randomized controlled trial Hepatology 31 2000 730-735